Mercury Biopharmaceutical (ROCO:6932) Gross-Profit-to-Asset % : 0.11% (As of Dec. 2024)

Mercury Biopharmaceutical Gross-Profit-to-Asset % Chart

Mercury Biopharmaceutical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial					-	-	0.26	1.95	0.11

Competitive Comparison of Mercury Biopharmaceutical's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Biopharmaceutical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mercury Biopharmaceutical's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Biopharmaceutical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Mercury Biopharmaceutical's Gross-Profit-to-Asset % falls into.

Mercury Biopharmaceutical Gross-Profit-to-Asset % Calculation

Mercury Biopharmaceutical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Mercury Biopharmaceutical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Mercury Biopharmaceutical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mercury Biopharmaceutical Business Description